A Phase 3, randomized, double-blind, study evaluating efficacy and safety of riliprubart versus intravenous immunoglobulin (IVIg) in participants with chronic inflammatory demyelinating polyneuropathy (VITALIZE)

Principal Investigator

Dr Simon Rinaldi

Contact us

Email: dendron@ouh.nhs.uk

IRAS number

1009620